Skip to main content Scroll Top
press-articles
Press articles
press-articles
Press articles
press-articles
Press articles
Most Viewed Posts
Clear Filters
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
Clear Filters
REGEnLIFE: light stimulation for neurological diseases
Concussion in sport: former rugby player Philippe Sella warns of long-term consequences
REGEnLIFE extends its technology to concussions
REGEnLIFE cures inflammatory brain diseases with light
THE GREAT CHALLENGES OF DEEPTECH (4/4). Every Friday, discover a disruptive innovation that could solve a major problem. This week, Montpellier-based Regenlife uses near-infrared light stimulation to treat concussions, certain neurodegenerative diseases such as Alzheimer's, and depression. The company is seeking to raise 10 million euros.
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases